|
Bacterial species
|
ESBL-E
|
pAmpC-E
|
CIP-RE
|
CIRE
|
|---|
|
n/N (%)a
|
n/N (%)a
|
n/N (%)a
|
n/N (%)a
|
|---|
|
Escherichia coli
|
101/107 (94.4)
|
13/15 (86.7)
|
51/51 (100.0)
|
2/6 (33.3)
|
|
Klebsiella pneumoniae
|
3/107 (2.8)
|
2/15 (13.3)
|
–
|
2/6 (33.3)
|
|
Klebsiella oxytoca
|
–
|
–
|
–
|
1/6 (16.7)
|
|
Enterobacter cloacae
|
1/107 (0.9)
|
–
|
–
|
–
|
|
Enterobacter aerogenes
|
1/107 (0.9)
|
–
|
–
|
1/6 (16.7)
|
|
Providencia rettgeri
|
1/107 (0.9)
|
–
|
–
|
–
|
|
Total n/N (%)b
|
107/500 (21.4)
|
15/500 (3.0)
|
51/500 (10.2)
|
6/500 (1.2)
|
- Abbreviations: ESBL-E Extended-spectrum β-lactamase-producing Enterobacteriaceae; pAmpC-E plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae, CIP-RE Ciprofloxacin-resistant Enterobacteriaceae, CIRE Carbapenem-intermediate or -resistant Enterobacteriaceae
- aIndicates the percentage of bacterial species among ESBL-E (N = 107), pAmpC-E (N = 15), CIP-RE (N = 51), or CIRE (N = 6) isolates
- bIndicates the percentage of ESBL-E, pAmpC-E, CIP-RE and CIRE isolates according to 500 samples
